CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: enniatin
Accession: CHEBI:64648
browse the term
Definition: A class of six-membered cyclodepsipeptides found in several species of Fusarium fungi as mixtures.
Synonyms: related_synonym: enniatins
alt_id: MESH:C100264
xref_mesh: MESH:C100264
xref: PMID:11772612; PMID:16535227; PMID:19065580; PMID:20621153; PMID:21352844; PMID:22008903; PMID:22070284; Wikipedia:Enniatin
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Abca1
ATP binding cassette subfamily A member 1
multiple interactions decreases expression
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ABCA1 mRNA enniatins results in decreased expression of ABCA1 mRNA
CTD
PMID:31100301
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:67,681,297...67,801,170
G
Abcg1
ATP binding cassette subfamily G member 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ABCG1 mRNA
CTD
PMID:31100301
NCBI chr20:9,128,056...9,184,312
Ensembl chr20:9,126,687...9,182,948
G
Acat2
acetyl-CoA acetyltransferase 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ACAT2 protein
CTD
PMID:32407736
NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:47,695,788...47,752,821
G
Acsl4
acyl-CoA synthetase long-chain family member 4
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ACSL4 protein
CTD
PMID:32407736
NCBI chr X:110,739,633...110,803,416
Ensembl chr X:105,942,799...106,006,427
G
Adm2
adrenomedullin 2
increases expression
ISO
enniatins results in increased expression of ADM2 mRNA
CTD
PMID:36016515
NCBI chr 7:120,393,179...120,394,965
Ensembl chr 7:120,393,179...120,396,331
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
decreases expression
EXP
enniatins results in decreased expression of AIFM1 mRNA
CTD
PMID:27163883
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:127,650,226...127,689,256
G
Ak4
adenylate kinase 4
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of AK4 mRNA
CTD
PMID:31100301
NCBI chr 5:121,154,565...121,214,403
Ensembl chr 5:116,039,616...116,098,618
G
Aldh5a1
aldehyde dehydrogenase 5 family, member A1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ALDH5A1 protein
CTD
PMID:32407736
NCBI chr17:40,560,373...40,586,711
Ensembl chr17:40,130,883...40,158,677
G
Anapc13
anaphase promoting complex subunit 13
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ANAPC13 protein
CTD
PMID:32407736
NCBI chr 8:112,084,405...112,092,821
Ensembl chr 8:103,205,520...103,213,936
G
Artn
artemin
increases expression
ISO
enniatins results in increased expression of ARTN mRNA
CTD
PMID:36016515
NCBI chr 5:131,458,596...131,470,193
Ensembl chr 5:131,464,756...131,468,025
G
Atg12
autophagy related 12
decreases expression
EXP
enniatins results in decreased expression of ATG12 mRNA
CTD
PMID:27163883
NCBI chr18:41,638,841...41,649,311
Ensembl chr18:39,452,191...39,462,418
G
Atg3
autophagy related 3
decreases expression
EXP
enniatins results in decreased expression of ATG3 mRNA
CTD
PMID:27163883
NCBI chr11:69,130,948...69,159,280
Ensembl chr11:55,624,917...55,653,224
G
Atp1a1
ATPase Na+/K+ transporting subunit alpha 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of ATP1A1 protein
CTD
PMID:32407736
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:189,020,722...189,048,837
G
Atp1a3
ATPase Na+/K+ transporting subunit alpha 3
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ATP1A3 protein
CTD
PMID:32407736
NCBI chr 1:89,700,645...89,729,782
Ensembl chr 1:80,572,796...80,601,918
G
Atp5pb
ATP synthase peripheral stalk-membrane subunit b
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ATP5PB protein
CTD
PMID:32407736
NCBI chr 2:196,112,459...196,123,737
Ensembl chr 2:193,424,047...193,435,418
G
Atp5pf
ATP synthase peripheral stalk subunit F6
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ATP5PF protein
CTD
PMID:32407736
NCBI chr11:37,368,045...37,375,721
Ensembl chr11:23,881,592...23,889,119
G
Bcl2l11
Bcl2-like 11
decreases expression
EXP
enniatins results in decreased expression of BCL2L11 mRNA
CTD
PMID:27163883
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
G
Bnip3l
BCL2 interacting protein 3 like
decreases expression
EXP
enniatins results in decreased expression of BNIP3L mRNA
CTD
PMID:27163883
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
G
Btf3l4
basic transcription factor 3-like 4
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of BTF3L4 protein
CTD
PMID:32407736
NCBI chr 5:128,796,594...128,816,219
Ensembl chr 5:123,567,907...123,586,866
G
Casp3
caspase 3
decreases expression
EXP
enniatins results in decreased expression of CASP3 mRNA
CTD
PMID:27163883
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
increases expression
ISO
enniatins results in increased expression of CAT mRNA
CTD
PMID:30259633
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Ccdc180
coiled-coil domain containing 180
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of CCDC180 protein
CTD
PMID:32407736
NCBI chr 5:64,950,522...65,019,127
Ensembl chr 5:60,154,910...60,223,522
G
Ccnb2
cyclin B2
decreases expression
EXP
enniatins results in decreased expression of CCNB2 mRNA
CTD
PMID:27163883
NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:71,087,595...71,100,874
G
Ccng1
cyclin G1
decreases expression
EXP
enniatins results in decreased expression of CCNG1 mRNA
CTD
PMID:27163883
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
G
Ccng2
cyclin G2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of CCNG2 mRNA
CTD
PMID:31100301
NCBI chr14:15,088,694...15,097,190
Ensembl chr14:14,804,322...14,812,830
G
Ccnl2
cyclin L2
increases expression
EXP
enniatins results in increased expression of CCNL2 mRNA
CTD
PMID:27163883
NCBI chr 5:171,698,951...171,711,037
Ensembl chr 5:166,417,508...166,436,882
G
Ccr5
C-C motif chemokine receptor 5
decreases expression
ISO
enniatins results in decreased expression of CCR5 mRNA
CTD
PMID:36016515
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:123,752,325...123,759,260
G
Cct5
chaperonin containing TCP1 subunit 5
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of CCT5 protein
CTD
PMID:32407736
NCBI chr 2:84,302,621...84,313,773
Ensembl chr 2:82,590,630...82,602,930
G
Cd47
Cd47 molecule
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of CD47 protein
CTD
PMID:32407736
NCBI chr11:64,374,816...64,438,763
Ensembl chr11:50,906,177...50,969,425
G
Cd69
Cd69 molecule
decreases expression
ISO
enniatins results in decreased expression of CD69 mRNA
CTD
PMID:36016515
NCBI chr 4:164,411,485...164,419,403
Ensembl chr 4:162,725,446...162,733,542
G
Cd81
Cd81 molecule
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of CD81 protein
CTD
PMID:32407736
NCBI chr 1:207,665,274...207,681,094
Ensembl chr 1:198,241,484...198,251,660
G
Cebpb
CCAAT/enhancer binding protein beta
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of CEBPB mRNA
CTD
PMID:31100301
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:156,397,052...156,399,473
G
Chac1
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
increases expression
ISO
enniatins results in increased expression of CHAC1 mRNA
CTD
PMID:36016515
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
G
Cisd2
CDGSH iron sulfur domain 2
decreases expression
EXP
enniatins results in decreased expression of CISD2 mRNA
CTD
PMID:27163883
NCBI chr 2:226,502,517...226,527,325
Ensembl chr 2:223,828,937...223,868,946
G
Cln8
CLN8, transmembrane ER and ERGIC protein
decreases expression
EXP
enniatins results in decreased expression of CLN8 mRNA
CTD
PMID:27163883
NCBI chr16:81,451,941...81,462,046
Ensembl chr16:74,749,662...74,759,774
G
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of CNP protein
CTD
PMID:32407736
NCBI chr10:86,011,504...86,018,063
Ensembl chr10:85,511,160...85,517,720
G
Coa6
cytochrome c oxidase assembly factor 6
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of COA6 protein
CTD
PMID:32407736
NCBI chr19:71,293,066...71,295,668
Ensembl chr19:54,395,742...54,399,407
G
Col6a2
collagen type VI alpha 2 chain
decreases expression
ISO
enniatins results in decreased expression of COL6A2 mRNA
CTD
PMID:36016515
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
G
Coro1c
coronin 1C
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of CORO1C protein
CTD
PMID:32407736
NCBI chr12:48,373,573...48,445,718
Ensembl chr12:42,712,991...42,785,179
G
Cplane2
ciliogenesis and planar polarity effector complex subunit 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of CPLANE2 protein
CTD
PMID:32407736
NCBI chr 5:158,798,503...158,799,451
Ensembl chr 5:153,515,376...153,522,508
G
Crim1
cysteine rich transmembrane BMP regulator 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of CRIM1 mRNA
CTD
PMID:31100301
NCBI chr 6:22,447,983...22,622,459
Ensembl chr 6:16,697,829...16,870,259
G
Csdc2
cold shock domain containing C2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of CSDC2 protein
CTD
PMID:32407736
NCBI chr 7:115,332,134...115,346,599
Ensembl chr 7:113,451,998...113,466,463
G
Ctps1
CTP synthase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of CTPS1 protein
CTD
PMID:32407736
NCBI chr 5:139,372,349...139,440,441
Ensembl chr 5:134,125,025...134,154,180
G
Ctsd
cathepsin D
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of CTSD protein
CTD
PMID:32407736
NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:197,527,467...197,539,488
G
Cxadr
CXADR, Ig-like cell adhesion molecule
decreases expression
EXP
enniatins results in decreased expression of CXADR mRNA
CTD
PMID:27163883
NCBI chr11:16,982,864...17,030,078
Ensembl chr11:16,982,860...17,030,046
G
Cxcl3
C-X-C motif chemokine ligand 3
decreases expression
ISO
enniatins results in decreased expression of CXCL1 mRNA
CTD
PMID:30259633
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,270,146...17,289,511
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
decreases expression
ISO
enniatins results in decreased expression of CYP11A mRNA
CTD
PMID:25625232
NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:58,404,669...58,434,338
G
Cyp11b2
cytochrome P450, family 11, subfamily b, polypeptide 2
increases expression
ISO
enniatins results in increased expression of CYP11B1 mRNA
CTD
PMID:25625232
NCBI chr 7:108,719,349...108,726,024
Ensembl chr 7:106,838,590...106,845,004
G
Cyp11b3
cytochrome P450, family 11, subfamily b, polypeptide 3
increases expression
ISO
enniatins results in increased expression of CYP11B2 mRNA
CTD
PMID:25625232
NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:106,808,559...106,814,048
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
decreases expression
ISO
enniatins results in decreased expression of CYP17A1 mRNA
CTD
PMID:25625232
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:245,535,462...245,541,573
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
increases expression
ISO
enniatins results in increased expression of CYP19A1 mRNA
CTD
PMID:25625232
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:54,553,165...54,580,758
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
enniatins results in increased expression of CYP1A1 mRNA
CTD
PMID:25625232
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp4f39
cytochrome P450, family 4, subfamily f, polypeptide 39
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of CYP4F22 protein
CTD
PMID:32407736
NCBI chr 7:12,082,821...12,156,076
Ensembl chr 7:11,433,371...11,536,181
G
Dctn6
dynactin subunit 6
decreases expression
EXP
enniatins results in decreased expression of DCTN6 mRNA
CTD
PMID:27163883
NCBI chr16:58,077,595...58,096,604
Ensembl chr16:58,077,585...58,096,968
G
Dcxr
dicarbonyl and L-xylulose reductase
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of DCXR protein
CTD
PMID:32407736
NCBI chr10:106,504,730...106,506,619
G
Ddx47
DEAD-box helicase 47
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of DDX47 protein
CTD
PMID:32407736
NCBI chr 4:169,577,013...169,589,473
Ensembl chr 4:167,845,640...167,859,115
G
Dhrs7
dehydrogenase/reductase 7
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of DHRS7 protein
CTD
PMID:32407736
NCBI chr 6:97,068,149...97,083,744
Ensembl chr 6:91,251,323...91,347,892
G
Dnm1
dynamin 1
decreases expression
EXP
enniatins results in decreased expression of DNM1 mRNA
CTD
PMID:27163883
NCBI chr 3:36,002,535...36,055,220
Ensembl chr 3:15,604,784...15,648,538
G
Egr1
early growth response 1
increases expression decreases expression
ISO
enniatins results in increased expression of EGR1 mRNA enniatins results in decreased expression of EGR1 mRNA
CTD
PMID:30227181 PMID:36016515
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Exph5
exophilin 5
increases expression
ISO
enniatins results in increased expression of EXPH5 mRNA
CTD
PMID:36016515
NCBI chr 8:53,698,825...53,775,371
Ensembl chr 8:53,698,852...53,773,169
G
Fmc1
formation of mitochondrial complex V assembly factor 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of FMC1 protein
CTD
PMID:32407736
NCBI chr 4:68,241,009...68,249,045
Ensembl chr 4:67,274,104...67,282,140
G
Gaa
alpha glucosidase
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of GAA protein
CTD
PMID:32407736
NCBI chr10:105,028,106...105,045,365
Ensembl chr10:104,529,747...104,546,836
G
Gabarapl1
GABA type A receptor associated protein like 1
decreases expression
EXP
enniatins results in decreased expression of GABARAPL1 mRNA
CTD
PMID:27163883
NCBI chr 4:164,666,332...164,675,474
Ensembl chr 4:162,980,249...162,989,450
G
Gna14
G protein subunit alpha 14
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of GNA14 protein
CTD
PMID:32407736
NCBI chr 1:223,141,802...223,324,210
Ensembl chr 1:213,716,020...213,897,423
G
Gnai3
G protein subunit alpha i3
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of GNAI3 protein
CTD
PMID:32407736
NCBI chr 2:198,430,920...198,468,874
Ensembl chr 2:195,742,642...195,780,742
G
Gnb1
G protein subunit beta 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of GNB1 protein
CTD
PMID:32407736
NCBI chr 5:171,357,778...171,424,489
Ensembl chr 5:166,075,629...166,142,124
G
Golga1
golgin A1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of GOLGA1 protein
CTD
PMID:32407736
NCBI chr 3:43,175,400...43,222,319
Ensembl chr 3:22,767,761...22,812,585
G
Golph3
golgi phosphoprotein 3
decreases expression
EXP
enniatins results in decreased expression of GOLPH3 mRNA
CTD
PMID:27163883
NCBI chr 2:61,348,030...61,376,051
Ensembl chr 2:61,348,030...61,376,049
G
Gpnmb
glycoprotein nmb
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of GPNMB protein
CTD
PMID:32407736
NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:78,010,197...78,049,367
G
Gpr17
G protein-coupled receptor 17
increases expression
ISO
enniatins results in increased expression of GPR17 mRNA
CTD
PMID:36016515
NCBI chr18:23,576,232...23,583,153
Ensembl chr18:23,577,242...23,582,966
G
Gpr18
G protein-coupled receptor 18
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of GPR18 mRNA
CTD
PMID:31100301
NCBI chr15:105,404,062...105,407,812
Ensembl chr15:98,997,259...99,001,470
G
Gpx1
glutathione peroxidase 1
increases expression
ISO
enniatins results in increased expression of GPX1 mRNA
CTD
PMID:30259633
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
G
Hexb
hexosaminidase subunit beta
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of HEXB protein
CTD
PMID:32407736
NCBI chr 2:30,218,608...30,238,771
Ensembl chr 2:28,484,012...28,504,223
G
Hist2h2be
histone cluster 2 H2B family member E
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of HIST2H2BE protein
CTD
PMID:32407736
NCBI chr 2:186,469,452...186,471,899
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
decreases expression
ISO
enniatins results in decreased expression of HMGCR mRNA
CTD
PMID:25625232
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:27,997,525...28,019,703
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression multiple interactions
ISO
enniatins results in increased expression of HMGCS1 mRNA [beauvericin co-treated with enniatins] results in decreased expression of HMGCS1 mRNA
CTD
PMID:31100301
NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:51,649,497...51,667,100
G
Hnrnpm
heterogeneous nuclear ribonucleoprotein M
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of HNRNPM protein
CTD
PMID:32407736
NCBI chr 7:15,140,877...15,178,871
Ensembl chr 7:14,438,688...14,476,762
G
Hnrnpu
heterogeneous nuclear ribonucleoprotein U
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of HNRNPU protein
CTD
PMID:32407736
NCBI chr13:92,609,791...92,618,580
Ensembl chr13:90,074,181...90,086,588
G
Hsd3b2
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
decreases expression
ISO
enniatins results in decreased expression of HSD3B2 mRNA
CTD
PMID:25625232
NCBI chr 2:188,784,614...188,812,535
Ensembl chr 2:186,095,897...186,101,852
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of HSPA5 mRNA
CTD
PMID:31100301
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
G
Igsf9
immunoglobulin superfamily, member 9
increases expression
ISO
enniatins results in increased expression of IGSF9 mRNA
CTD
PMID:36016515
NCBI chr13:84,948,643...84,965,616
Ensembl chr13:84,948,619...84,965,607
G
Il1b
interleukin 1 beta
decreases expression
ISO
enniatins results in decreased expression of IL1B mRNA
CTD
PMID:30259633
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Immt
inner membrane mitochondrial protein
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of IMMT protein
CTD
PMID:32407736
NCBI chr 4:105,438,657...105,477,370
Ensembl chr 4:103,880,459...103,919,109
G
Islr2
immunoglobulin superfamily containing leucine-rich repeat 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ISLR2 protein
CTD
PMID:32407736
NCBI chr 8:67,504,042...67,512,125
Ensembl chr 8:58,608,709...58,614,650
G
Itgb1
integrin subunit beta 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of ITGB1 protein
CTD
PMID:32407736
NCBI chr19:73,602,277...73,650,271
Ensembl chr19:56,705,171...56,753,195
G
Jph3
junctophilin 3
increases expression
ISO
enniatins results in increased expression of JPH3 mRNA
CTD
PMID:36016515
NCBI chr19:49,793,967...49,855,338
Ensembl chr19:49,793,092...49,855,338
G
Klf12
KLF transcription factor 12
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of KLF12 protein
CTD
PMID:32407736
NCBI chr15:83,037,548...83,469,998
Ensembl chr15:76,637,654...77,062,056
G
Kpnb1
karyopherin subunit beta 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of KPNB1 protein
CTD
PMID:32407736
NCBI chr10:82,642,082...82,670,856
Ensembl chr10:82,145,420...82,174,605
G
Krt16
keratin 16
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of KRT16 protein
CTD
PMID:32407736
NCBI chr10:85,669,276...85,672,211
Ensembl chr10:85,066,802...85,171,799
G
Krt27
keratin 27
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of KRT27 protein
CTD
PMID:32407736
NCBI chr10:84,794,848...84,800,131
Ensembl chr10:84,298,508...84,303,967
G
Krt5
keratin 5
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of KRT5 protein
CTD
PMID:32407736
NCBI chr 7:134,724,840...134,730,569
Ensembl chr 7:132,846,136...132,851,850
G
Krt76
keratin 76
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of KRT76 protein
CTD
PMID:32407736
NCBI chr 7:134,895,677...134,904,162
Ensembl chr 7:133,016,992...133,025,496
G
Lamp2
lysosomal-associated membrane protein 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of LAMP2 protein
CTD
PMID:32407736
NCBI chr X:122,038,734...122,087,745
Ensembl chr X:117,057,606...117,260,522
G
Malsu1
mitochondrial assembly of ribosomal large subunit 1
decreases expression
EXP
enniatins results in decreased expression of MALSU1 mRNA
CTD
PMID:27163883
NCBI chr 4:78,051,090...78,059,913
Ensembl chr 4:78,051,059...78,059,905
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
decreases expression
EXP
enniatins results in decreased expression of MAP3K1 mRNA
CTD
PMID:27163883
NCBI chr 2:45,081,889...45,150,555
Ensembl chr 2:43,350,098...43,414,463
G
Matn4
matrilin 4
increases expression
ISO
enniatins results in increased expression of MATN4 mRNA
CTD
PMID:36016515
NCBI chr 3:173,539,966...173,554,984
Ensembl chr 3:153,120,632...153,135,865
G
Mc2r
melanocortin 2 receptor
increases expression
ISO
enniatins results in increased expression of MC2R mRNA
CTD
PMID:25625232
NCBI chr18:62,001,980...62,015,567
Ensembl chr18:62,004,948...62,015,488
G
Med6
mediator complex subunit 6
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of MED6 protein
CTD
PMID:32407736
NCBI chr 6:107,001,664...107,015,130
Ensembl chr 6:101,270,410...101,283,876
G
Mef2a
myocyte enhancer factor 2a
decreases expression
EXP
enniatins results in decreased expression of MEF2A mRNA
CTD
PMID:27163883
NCBI chr 1:120,847,874...120,982,488
Ensembl chr 1:120,850,080...120,981,948
G
Mief1
mitochondrial elongation factor 1
decreases expression
EXP
enniatins results in decreased expression of MIEF1 mRNA
CTD
PMID:27163883
NCBI chr 7:111,786,630...111,802,220
Ensembl chr 7:111,786,709...111,802,220
G
Mpv17l
MPV17 mitochondrial inner membrane protein like
decreases expression
EXP
enniatins results in decreased expression of MPV17L mRNA
CTD
PMID:27163883
NCBI chr10:2,495,605...2,532,448
Ensembl chr10:1,988,136...2,007,649
G
Mrpl12
mitochondrial ribosomal protein L12
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of MRPL12 mRNA; [Plant Extracts co-treated with enniatins] results in decreased expression of MRPL12 mRNA
CTD
PMID:31100301 PMID:31904472
NCBI chr10:106,256,746...106,261,249
Ensembl chr10:105,758,410...105,762,913
G
Mt-atp6
mitochondrially encoded ATP synthase membrane subunit 6
decreases expression multiple interactions
ISO
enniatins results in decreased expression of ATP6 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ATP6 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ATP6 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ATP6 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of ATP6 mRNA
CTD
PMID:30227181 PMID:31100301 PMID:31904472 PMID:34015425 PMID:36016515
NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
G
Mt-atp8
mitochondrially encoded ATP synthase membrane subunit 8
decreases expression multiple interactions
ISO
enniatins results in decreased expression of ATP8 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ATP8 mRNA; [beauvericin co-treated with enniatins] affects the expression of ATP8 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with enniatins] results in decreased expression of ATP8 mRNA
CTD
PMID:30227181 PMID:31100301 PMID:31904472 PMID:34015425 PMID:36016515
NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
G
Mt-co1
mitochondrially encoded cytochrome c oxidase I
multiple interactions decreases expression
ISO
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of COX1 mRNA; [beauvericin co-treated with enniatins] affects the expression of COX1 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with enniatins] results in decreased expression of COX1 mRNA enniatins results in decreased expression of COX1 mRNA
CTD
PMID:31100301 PMID:31904472 PMID:34015425 PMID:36016515
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
G
Mt-co2
mitochondrially encoded cytochrome c oxidase II
decreases expression
ISO
enniatins results in decreased expression of COX2 mRNA
CTD
PMID:36016515
NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
G
Mt-co3
mitochondrially encoded cytochrome c oxidase III
decreases expression multiple interactions
ISO
enniatins results in decreased expression of COX3 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of COX3 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of COX3 mRNA
CTD
PMID:31100301 PMID:34015425 PMID:36016515
NCBI chr MT:8,599...9,382
Ensembl chr MT:8,599...9,382
G
Mt-cyb
mitochondrially encoded cytochrome b
decreases expression
ISO
enniatins results in decreased expression of CYTB mRNA
CTD
PMID:30227181 PMID:36016515
NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
G
Mt-nd1
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
decreases expression
ISO
enniatins results in decreased expression of ND1 mRNA
CTD
PMID:30227181 PMID:36016515
NCBI chr MT:2,740...3,694
Ensembl chr MT:2,740...3,694
G
Mt-nd2
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2
decreases expression multiple interactions
ISO
enniatins results in decreased expression of ND2 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND2 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND2 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND2 mRNA
CTD
PMID:30227181 PMID:31100301 PMID:31904472 PMID:34015425 PMID:36016515
NCBI chr MT:3,904...4,942
Ensembl chr MT:3,904...4,942
G
Mt-nd3
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3
decreases expression multiple interactions increases expression
ISO
enniatins results in decreased expression of ND3 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND3 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND3 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with enniatins] results in increased expression of ND3 mRNA enniatins results in increased expression of ND3 mRNA
CTD
PMID:30227181 PMID:31100301 PMID:31904472 PMID:34015425 PMID:36016515
NCBI chr MT:9,451...9,798
Ensembl chr MT:9,451...9,798
G
Mt-nd4
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4
decreases expression multiple interactions
ISO
enniatins results in decreased expression of ND4 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ND4 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND4 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ND4 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND4 mRNA; [Plant Extracts co-treated with enniatins] results in increased expression of ND4 mRNA
CTD
PMID:30227181 PMID:31100301 PMID:31904472 PMID:34015425 PMID:36016515
NCBI chr MT:10,160...11,537
Ensembl chr MT:10,160...11,537
G
Mt-nd4l
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L
decreases expression multiple interactions
ISO
enniatins results in decreased expression of ND4L mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND4L mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND4L mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND4L mRNA
CTD
PMID:30227181 PMID:34015425 PMID:36016515
NCBI chr MT:9,870...10,166
Ensembl chr MT:9,870...10,166
G
Mt-nd5
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5
decreases expression multiple interactions
ISO
enniatins results in decreased expression of ND5 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND5 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND5 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND5 mRNA
CTD
PMID:30227181 PMID:31100301 PMID:31904472 PMID:34015425 PMID:36016515
NCBI chr MT:11,736...13,565
Ensembl chr MT:11,736...13,565
G
Mt-nd6
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6
decreases expression multiple interactions
ISO
enniatins results in decreased expression of ND6 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ND6 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND6 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND6 mRNA
CTD
PMID:30227181 PMID:34015425 PMID:36016515
NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
G
Mterf4
mitochondrial transcription termination factor 4
decreases expression
EXP
enniatins results in decreased expression of MTERF4 mRNA
CTD
PMID:27163883
NCBI chr 9:93,834,162...93,838,838
Ensembl chr 9:93,834,144...93,838,864
G
Mtrf1l
mitochondrial translation release factor 1 like
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of MTRF1L protein
CTD
PMID:32407736
NCBI chr 1:44,614,162...44,626,367
Ensembl chr 1:42,210,583...42,220,836
G
Nars1
asparaginyl-tRNA synthetase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of NARS1 protein
CTD
PMID:32407736
NCBI chr18:60,259,506...60,275,782
Ensembl chr18:57,989,308...58,005,622
G
Nars2
asparaginyl-tRNA synthetase 2, mitochondrial
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of NARS2 protein
CTD
PMID:32407736
NCBI chr 1:160,711,680...160,823,311
Ensembl chr 1:151,300,467...151,413,521
G
Ndrg1
N-myc downstream regulated 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of NDRG1 protein
CTD
PMID:32407736
NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:98,684,487...98,725,880
G
Ndufs4
NADH:ubiquinone oxidoreductase subunit S4
decreases expression
EXP
enniatins results in decreased expression of NDUFS4 mRNA
CTD
PMID:27163883
NCBI chr 2:47,684,420...47,794,914
Ensembl chr 2:45,951,313...46,061,846
G
Niban1
niban apoptosis regulator 1
increases expression
ISO
enniatins results in increased expression of NIBAN1 mRNA
CTD
PMID:36016515
NCBI chr13:63,674,240...63,827,748
Ensembl chr13:63,674,171...63,827,729
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of NQO1 mRNA
CTD
PMID:31100301
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nr0b1
nuclear receptor subfamily 0, group B, member 1
increases expression
ISO
enniatins results in increased expression of NR0B1 mRNA
CTD
PMID:25625232
NCBI chr X:50,756,886...50,761,014
Ensembl chr X:50,756,886...50,761,011
G
Nrf1
nuclear respiratory factor 1
decreases expression
EXP
enniatins results in decreased expression of NRF1 mRNA
CTD
PMID:27163883
NCBI chr 4:59,632,366...59,738,166
Ensembl chr 4:58,664,957...58,825,328
G
Nudt1
nudix hydrolase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of NUDT1 protein
CTD
PMID:32407736
NCBI chr12:19,416,411...19,423,448
Ensembl chr12:14,302,694...14,305,826
G
Osgin1
oxidative stress induced growth inhibitor 1
increases expression multiple interactions
ISO
enniatins results in increased expression of OSGIN1 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of OSGIN1 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of OSGIN1 mRNA
CTD
PMID:31100301 PMID:34015425 PMID:36016515
NCBI chr19:64,380,336...64,409,165
Ensembl chr19:47,492,171...47,500,516
G
Ostc
oligosaccharyltransferase complex non-catalytic subunit
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of OSTC protein
CTD
PMID:32407736
NCBI chr 2:221,924,727...221,940,253
Ensembl chr 2:219,236,952...219,266,107
G
Pam16
presequence translocase associated motor 16
decreases expression
EXP
enniatins results in decreased expression of PAM16 mRNA
CTD
PMID:27163883
NCBI chr10:10,942,534...10,950,654
Ensembl chr10:10,943,001...10,950,649
G
Parvg
parvin, gamma
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PARVG protein
CTD
PMID:32407736
NCBI chr 7:117,336,160...117,366,341
Ensembl chr 7:115,456,209...115,475,104
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
increases expression
ISO
enniatins results in increased expression of PCK2 mRNA
CTD
PMID:36016515
NCBI chr15:32,997,853...33,006,691
Ensembl chr15:29,027,894...29,037,283
G
Pfn1
profilin 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PFN1 protein
CTD
PMID:32407736
NCBI chr10:55,863,882...55,866,587
Ensembl chr10:55,365,262...55,527,631
G
Pgam1
phosphoglycerate mutase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PGAM1 protein
CTD
PMID:32407736
NCBI chr 1:250,673,152...250,680,762
Ensembl chr 1:240,723,920...240,738,452
G
Pgk1
phosphoglycerate kinase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PGK1 protein
CTD
PMID:32407736
NCBI chr X:75,336,988...75,352,962
Ensembl chr X:71,271,440...71,287,418
G
Phgdh
phosphoglycerate dehydrogenase
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PHGDH protein
CTD
PMID:32407736
NCBI chr 2:188,595,700...188,624,789
Ensembl chr 2:185,906,966...185,935,944
G
Phka2
phosphorylase kinase regulatory subunit alpha 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of PHKA2 protein
CTD
PMID:32407736
NCBI chr X:37,979,629...38,102,656
Ensembl chr X:34,171,323...34,293,466
G
Pls3
plastin 3
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of PLS3 protein
CTD
PMID:32407736
NCBI chr X:116,401,247...116,495,898
Ensembl chr X:111,589,254...111,683,891
G
Ppa1
inorganic pyrophosphatase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PPA1 protein
CTD
PMID:32407736
NCBI chr20:30,132,088...30,160,492
Ensembl chr20:29,590,707...29,619,215
G
Ppp2cb
protein phosphatase 2 catalytic subunit beta
decreases expression
EXP
enniatins results in decreased expression of PPP2CB mRNA
CTD
PMID:27163883
NCBI chr16:65,261,178...65,282,658
Ensembl chr16:58,558,122...58,579,576
G
Ppt1
palmitoyl-protein thioesterase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of PPT1 protein
CTD
PMID:32407736
NCBI chr 5:140,406,318...140,427,201
Ensembl chr 5:135,121,163...135,142,048
G
Prkca
protein kinase C, alpha
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PRKCA protein
CTD
PMID:32407736
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:92,894,012...93,288,012
G
Psma5
proteasome 20S subunit alpha 5
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PSMA5 protein
CTD
PMID:32407736
NCBI chr 2:198,584,502...198,607,867
Ensembl chr 2:195,896,365...195,919,731
G
Psme4
proteasome activator subunit 4
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of PSME4 protein
CTD
PMID:32407736
NCBI chr14:108,706,643...108,810,330
Ensembl chr14:104,505,716...104,609,408
G
Ptgds
prostaglandin D2 synthase
decreases expression
ISO
enniatins results in decreased expression of PTGDS mRNA
CTD
PMID:30227181
NCBI chr 3:28,680,044...28,682,978
Ensembl chr 3:8,281,899...8,284,833
G
Ptges3
prostaglandin E synthase 3
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PTGES3 protein
CTD
PMID:32407736
NCBI chr 7:1,075,230...1,092,363
Ensembl chr 7:490,656...508,084
G
Ptgs1
prostaglandin-endoperoxide synthase 1
decreases expression
ISO
enniatins results in decreased expression of PTGS1 mRNA
CTD
PMID:30227181
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
enniatins results in decreased expression of PTGS2 mRNA
CTD
PMID:30227181
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ptprc
protein tyrosine phosphatase, receptor type, C
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PTPRC protein
CTD
PMID:32407736
NCBI chr13:52,147,717...52,259,810
Ensembl chr13:49,596,193...49,708,692
G
Rab11fip5
RAB11 family interacting protein 5
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of RAB11FIP5 protein
CTD
PMID:32407736
NCBI chr 4:119,428,766...119,466,277
Ensembl chr 4:117,871,308...117,908,741
G
Rab5a
RAB5A, member RAS oncogene family
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of RAB5A protein
CTD
PMID:32407736
NCBI chr 9:6,720,057...6,749,456
Ensembl chr 9:6,484,469...6,512,873
G
Rac3
Rac family small GTPase 3
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of RAC3 protein
CTD
PMID:32407736
NCBI chr10:106,501,133...106,503,569
Ensembl chr10:105,993,087...106,005,260
G
Rap1a
RAP1A, member of RAS oncogene family
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of RAP1A protein
CTD
PMID:32407736
NCBI chr 2:195,896,967...195,974,851
Ensembl chr 2:193,208,635...193,286,501
G
Rp2
RP2 activator of ARL3 GTPase
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of RP2 protein
CTD
PMID:32407736
NCBI chr X:4,426,071...4,470,200
Ensembl chr X:1,873,306...1,916,688
G
Rpl37a
ribosomal protein L37A
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of RPL37A protein
CTD
PMID:32407736
NCBI chr 9:81,748,091...81,750,174
G
Rpl5
ribosomal protein L5
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of RPL5 protein
CTD
PMID:32407736
NCBI chr14:1,988,792...1,995,236
Ensembl chr14:1,843,770...1,850,290
G
Rpl8
ribosomal protein L8
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of RPL8 protein
CTD
PMID:32407736
NCBI chr 7:110,506,815...110,509,106
Ensembl chr 7:108,622,324...108,628,482 Ensembl chr 3:108,622,324...108,628,482
G
Rrm2b
ribonucleotide reductase regulatory TP53 inducible subunit M2B
decreases expression
EXP
enniatins results in decreased expression of RRM2B mRNA
CTD
PMID:27163883
NCBI chr 7:70,962,008...70,993,726
Ensembl chr 7:69,078,291...69,108,633
G
Rxra
retinoid X receptor alpha
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of RXRA protein
CTD
PMID:32407736
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:10,989,832...11,073,712
G
Scml2
Scm polycomb group protein like 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of SCML2 protein
CTD
PMID:32407736
NCBI chr X:37,331,893...37,486,465
Ensembl chr X:33,524,530...33,652,742
G
Sdf2l1
stromal cell-derived factor 2-like 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of SDF2L1 protein
CTD
PMID:32407736
NCBI chr11:97,376,878...97,379,120
Ensembl chr11:83,872,659...83,874,902
G
Sdr42e2
short chain dehydrogenase/reductase family 42E, member 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of SDR42E2 protein
CTD
PMID:32407736
NCBI chr 1:184,788,773...184,814,064
Ensembl chr 1:175,362,150...175,382,050
G
Sh3glb1
SH3 domain -containing GRB2-like endophilin B1
decreases expression
EXP
enniatins results in decreased expression of SH3GLB1 mRNA
CTD
PMID:27163883
NCBI chr 2:233,750,838...233,784,817
Ensembl chr 2:233,750,838...233,784,784
G
Slc1a5
solute carrier family 1 member 5
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of SLC1A5 protein
CTD
PMID:32407736
NCBI chr 1:86,584,949...86,599,052
Ensembl chr 1:77,456,694...77,470,952
G
Slc22a20
solute carrier family 22 member 20
increases expression
ISO
enniatins results in increased expression of SLC22A20P mRNA
CTD
PMID:36016515
NCBI chr 1:203,257,374...203,273,854
Ensembl chr 1:203,257,374...203,273,822
G
Slc2a1
solute carrier family 2 member 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of SLC2A1 protein
CTD
PMID:32407736
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:132,717,196...132,745,416
G
Slc3a2
solute carrier family 3 member 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of SLC3A2 protein
CTD
PMID:32407736
NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:205,604,468...205,618,931
G
Slc6a9
solute carrier family 6 member 9
increases expression
ISO
enniatins results in increased expression of SLC6A9 mRNA
CTD
PMID:36016515
NCBI chr 5:131,374,562...131,408,733
Ensembl chr 5:131,374,542...131,408,728
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
enniatins results in increased expression of SLC7A11 mRNA
CTD
PMID:30227181 PMID:31100301 PMID:36016515
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:133,963,107...134,517,536
G
Slit2
slit guidance ligand 2
decreases expression
ISO
enniatins results in decreased expression of SLIT2 mRNA
CTD
PMID:36016515
NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948
G
Snrpd2
small nuclear ribonucleoprotein D2 polypeptide
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of SNRPD2 protein
CTD
PMID:32407736
NCBI chr 1:87,926,030...87,929,259
Ensembl chr 1:78,798,377...78,803,351 Ensembl chr20:78,798,377...78,803,351
G
Snrpd3
small nuclear ribonucleoprotein D3 polypeptide
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of SNRPD3 protein
CTD
PMID:32407736
NCBI chr20:13,129,555...13,145,100
Ensembl chr20:13,130,119...13,145,978
G
Sod1
superoxide dismutase 1
increases expression
ISO
enniatins results in increased expression of SOD1 mRNA
CTD
PMID:30259633
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
increases expression
ISO
enniatins results in increased expression of SOD2 mRNA
CTD
PMID:30259633
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Spns3
SPNS lysolipid transporter 3, sphingosine-1-phosphate
increases expression
ISO
enniatins results in increased expression of SPNS3 mRNA
CTD
PMID:36016515
NCBI chr10:57,114,247...57,169,056
Ensembl chr10:57,114,266...57,168,951
G
Srsf7
serine and arginine rich splicing factor 7
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of SRSF7 protein
CTD
PMID:32407736
NCBI chr 6:20,564,035...20,571,205
Ensembl chr 6:14,811,808...14,818,965
G
Srxn1
sulfiredoxin 1
multiple interactions
ISO
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of SRXN1 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of SRXN1 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of SRXN1 mRNA
CTD
PMID:31100301 PMID:34015425
NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:140,599,608...140,628,448
G
Ssbp1
single stranded DNA binding protein 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of SSBP1 protein
CTD
PMID:32407736
NCBI chr 4:70,232,740...70,242,824
Ensembl chr 4:69,266,102...69,276,135
G
Sspo
SCO-spondin
decreases expression
ISO
enniatins results in decreased expression of SSPO mRNA
CTD
PMID:36016515
NCBI chr 4:78,725,829...78,781,330
Ensembl chr 4:77,397,059...77,450,412
G
Star
steroidogenic acute regulatory protein
decreases expression
ISO
enniatins results in decreased expression of STAR mRNA
CTD
PMID:25625232
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:66,264,807...66,271,672
G
Stc2
stanniocalcin 2
increases expression
ISO
enniatins results in increased expression of STC2 mRNA
CTD
PMID:30227181 PMID:36016515
NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,250,853...16,262,973
G
Tbc1d2b
TBC1 domain family, member 2B
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of TBC1D2B protein
CTD
PMID:32407736
NCBI chr 8:99,626,019...99,694,669
Ensembl chr 8:90,746,233...90,814,832
G
Tcn2
transcobalamin 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of TCN2 protein
CTD
PMID:32407736
NCBI chr14:83,036,935...83,052,187
Ensembl chr14:78,813,343...78,828,489
G
Tcp11l1
t-complex 11 like 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of TCP11L1 protein
CTD
PMID:32407736
NCBI chr 3:111,478,787...111,547,553
Ensembl chr 3:90,998,270...91,092,006
G
Tcp11l2
t-complex 11 like 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of TCP11L2 protein
CTD
PMID:32407736
NCBI chr 7:21,037,955...21,072,857
Ensembl chr 7:19,150,252...19,185,095
G
Tfb2m
transcription factor B2, mitochondrial
decreases expression
EXP
enniatins results in decreased expression of TFB2M mRNA
CTD
PMID:27163883
NCBI chr13:93,810,859...93,828,678
Ensembl chr13:91,278,898...91,296,657
G
Thyn1
thymocyte nuclear protein 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of THYN1 protein
CTD
PMID:32407736
NCBI chr 8:33,665,614...33,674,593
Ensembl chr 8:25,406,500...25,415,445
G
Timm21
translocase of inner mitochondrial membrane 21
decreases expression
EXP
enniatins results in decreased expression of TIMM21 mRNA
CTD
PMID:27163883
NCBI chr18:80,589,775...80,594,237
Ensembl chr18:78,314,909...78,319,454
G
Timm8b
translocase of inner mitochondrial membrane 8 homolog B
decreases expression
EXP
enniatins results in decreased expression of TIMM8B mRNA
CTD
PMID:27163883
NCBI chr 8:59,850,737...59,852,117
Ensembl chr 8:50,954,342...50,955,729
G
Timm9
translocase of inner mitochondrial membrane 9
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of TIMM9 protein
CTD
PMID:32407736
NCBI chr 6:95,346,065...95,358,895
Ensembl chr 6:89,610,094...89,622,924
G
Tk1
thymidine kinase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of TK1 protein
CTD
PMID:32407736
NCBI chr10:103,533,449...103,544,818
Ensembl chr10:103,031,521...103,046,920
G
Tmem11
transmembrane protein 11
decreases expression
EXP
enniatins results in decreased expression of TMEM11 mRNA
CTD
PMID:27163883
NCBI chr10:45,542,753...45,557,570
Ensembl chr10:45,542,755...45,557,570 Ensembl chr 6:45,542,755...45,557,570
G
Tmem263
transmembrane protein 263
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of TMEM263 protein
CTD
PMID:32407736
NCBI chr 7:20,497,852...20,516,011
Ensembl chr 7:18,610,149...18,628,534
G
Tnfsf10
TNF superfamily member 10
decreases expression
EXP
enniatins results in decreased expression of TNFSF10 mRNA
CTD
PMID:27163883
NCBI chr 2:112,136,550...112,155,903
Ensembl chr 2:110,207,916...110,225,135
G
Tomm22
translocase of outer mitochondrial membrane 22
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of TOMM22 protein
CTD
PMID:32407736
NCBI chr 7:113,103,863...113,109,056
Ensembl chr 7:111,216,571...111,246,799
G
Tomm5
translocase of outer mitochondrial membrane 5
decreases expression
EXP
enniatins results in decreased expression of TOMM5 mRNA
CTD
PMID:27163883
NCBI chr 5:59,362,360...59,365,191
Ensembl chr 5:59,362,240...59,365,269
G
Tomm7
translocase of outer mitochondrial membrane 7
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of TOMM7 protein
CTD
PMID:32407736
NCBI chr 4:12,197,503...12,204,344
Ensembl chr 4:11,305,110...11,311,962
G
Trmt10c
tRNA methyltransferase 10C, mitochondrial RNase P subunit
decreases expression
EXP
enniatins results in decreased expression of TRMT10C mRNA
CTD
PMID:27163883
NCBI chr11:44,584,388...44,589,466
Ensembl chr11:44,584,113...44,589,568
G
Tuba1b
tubulin, alpha 1B
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of TUBA1B protein
CTD
PMID:32407736
NCBI chr 7:131,969,606...131,972,587
Ensembl chr 7:130,081,032...130,196,186
G
Tubb3
tubulin, beta 3 class III
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of TUBB3 protein
CTD
PMID:32407736
NCBI chr19:68,365,687...68,374,741
Ensembl chr19:51,457,184...51,466,243
G
Tubb4a
tubulin, beta 4A class IVa
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of TUBB4A protein
CTD
PMID:32407736
NCBI chr 9:2,004,836...2,012,281
Ensembl chr 9:1,917,845...1,925,291
G
Tubb4b
tubulin, beta 4B class IVb
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of TUBB4B protein
CTD
PMID:32407736
NCBI chr 3:28,435,999...28,438,455
Ensembl chr 3:8,037,799...8,040,296
G
Tubb5
tubulin, beta 5 class I
decreases expression multiple interactions
EXP ISO
enniatins results in decreased expression of TUBB5 mRNA [beauvericin co-treated with enniatins] results in increased expression of TUBB protein
CTD
PMID:27163883 PMID:32407736
NCBI chr20:2,917,577...2,921,726
Ensembl chr20:2,912,778...2,916,940
G
Txnip
thioredoxin interacting protein
increases expression multiple interactions
ISO
enniatins results in increased expression of TXNIP mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of TXNIP mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of TXNIP mRNA; [Plant Extracts co-treated with enniatins] results in increased expression of TXNIP mRNA
CTD
PMID:31100301 PMID:31904472 PMID:34015425
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:184,092,991...184,096,886
G
Ucp1
uncoupling protein 1
increases expression
ISO
enniatins results in increased expression of UCP1 mRNA
CTD
PMID:30227181 PMID:36016515
NCBI chr19:41,713,350...41,721,421
Ensembl chr19:24,808,783...24,816,852
G
Ucp2
uncoupling protein 2
multiple interactions
ISO
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of UCP2 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of UCP2 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of UCP2 mRNA
CTD
PMID:31100301 PMID:34015425
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:154,839,209...154,845,611
G
Ucp3
uncoupling protein 3
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of UCP3 mRNA
CTD
PMID:31100301
NCBI chr 1:164,227,910...164,240,893
Ensembl chr 1:154,815,777...154,828,762
G
Vgll3
vestigial-like family member 3
increases expression
ISO
enniatins results in increased expression of VGLL3 mRNA
CTD
PMID:36016515
NCBI chr11:3,642,993...3,692,590
Ensembl chr11:3,643,069...3,689,140
G
Vpreb1a
V-set pre-B cell surrogate light chain 1A
increases expression
ISO
enniatins results in increased expression of VPREB1 mRNA
CTD
PMID:31100301
NCBI chr11:97,631,174...97,632,051
Ensembl chr11:84,126,969...84,127,846
G
Ykt6
YKT6 v-SNARE homolog
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of YKT6 protein
CTD
PMID:32407736
NCBI chr14:85,041,393...85,057,347
Ensembl chr14:80,832,187...80,843,385
G
Ywhag
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma
decreases expression
EXP
enniatins results in decreased expression of YWHAG mRNA
CTD
PMID:27163883
NCBI chr12:26,381,106...26,409,466
Ensembl chr12:20,744,535...20,772,827
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all